{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:23:07Z","timestamp":1771471387870,"version":"3.50.1"},"reference-count":18,"publisher":"American Association of Zoo Veterinarians","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Zoo and Wildlife Medicine"],"published-print":{"date-parts":[[2024,1,9]]},"DOI":"10.1638\/2022-0106","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:47:57Z","timestamp":1704797277000},"source":"Crossref","is-referenced-by-count":1,"title":["PROTOCOL FOR HUMAN EXPOSURE TO OPIOIDS AND CONCENTRATED MEDETOMIDINE USED IN FIELD APPLICATIONS"],"prefix":"10.1638","volume":"54","author":[{"given":"Jenny G.","family":"Powers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Y.","family":"McCue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Handrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Stroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas D.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Darracq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle E.","family":"Buttke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren A.","family":"Hilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Lance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1213","reference":[{"key":"12","unstructured":"TJ Kreeger  and JM Arnemo  \"Handbook of wildlife chemical immobilization.\"  (2018)"},{"key":"1","doi-asserted-by":"crossref","unstructured":"M Al-Azzawi, A Alshami, S Douedi, et al.  \"Am J Case Rep.\"  \"Naloxone-induced acute pulmonary edema is dose-dependent: a case series.\" 2021","DOI":"10.12659\/AJCR.929412"},{"key":"2","doi-asserted-by":"crossref","unstructured":"WM Burnside, PA Flecknell, AI Cameron, et al.  \"BMC Vet Res.\"  \"A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice.\" (2013)","DOI":"10.1186\/1746-6148-9-48"},{"key":"3","doi-asserted-by":"crossref","unstructured":"S Elkattawy, R Alyacoub, C Ejikeme, et al.  \"J Community Hosp Intern Med Perspect.\"  11, \"Naloxone induced pulmonary edema.\" 139 (2021)","DOI":"10.1080\/20009666.2020.1854417"},{"key":"4","doi-asserted-by":"crossref","unstructured":"A Farkas, MJ Lynch, R Westover, et al.  \"Ann Emerg Med.\"  75, \"Pulmonary complications of opioid overdose treated with naloxone.\" 39 (2020)","DOI":"10.1016\/j.annemergmed.2019.04.006"},{"key":"5","unstructured":"M Greenberg, A Rama, JR Zuba,  \"Internet J Toxicol.\"  \"A protocol for the emergency treatment of alpha-2 agonist overdose using atipamezole, a selective alpha-2 antagonist.\" (2017)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"M Greenberg, A Rama, JR Zuba,  \"Am J Emerg Med.\"  36, \"Atipamezole as an emergency treatment for overdose from highly concentrated alpha-2 agonists used in zoo and wildlife anesthesia.\" 136 (2018)","DOI":"10.1016\/j.ajem.2017.06.054"},{"key":"7","doi-asserted-by":"crossref","unstructured":"A Haymerle, A Fahlman, C Walzer,  \"Vet Rec.\"  167, \"Human exposures to immobilizing agents: results of an online survey.\" 327 (2010)","DOI":"10.1136\/vr.c4191"},{"key":"8","doi-asserted-by":"crossref","unstructured":"S Karhuvaara, A Kallio, M Salonen, et al.  \"Br J Clin Pharmacol.\"  31, \"Rapid reversal of \u03b12-adrenoreceptor agonist effects by atipamezole in human volunteers.\" 160 (1991)","DOI":"10.1111\/j.1365-2125.1991.tb05505.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"S Karhuvaara, A Kallio, M Scheinin, et al.  \"Br J Clin Pharmacol.\"  30, \"Pharmacological effects and pharmacokinetics of atipamezole, a novel \u03b12-adrenoceptor antagonist\u2014a randomized, double-blind cross-over study in healthy male volunteers.\" 97 (1990)","DOI":"10.1111\/j.1365-2125.1990.tb03748.x"},{"key":"10","unstructured":"S Karhuvaara, A Kallio, M Scheinin, et al.  \"Curr Ther Res Clin Exp.\"  45, \"Tolerability and effects of atipamezole, a novel alpha2-adrenoceptor antagonist, in healthy male volunteers.\" 633 (1989)"},{"key":"11","unstructured":"\"Chemical and physical restraint of African wild animals.\"  (2021)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"JH O'Dell, MD Kock, PN Thompson, et al.  \"Vet Rec.\"  \"Minimum effective naltrexone dose to antagonize etorphine immobilization and prevent the complications of renarcotisation in domestic goats.\" (2017)","DOI":"10.1136\/vr.104435"},{"key":"14","doi-asserted-by":"crossref","unstructured":"JL. Reid,  \"Am J Cardiol.\"  57, \"Alpha-adrenergic receptors and blood pressure control.\" 6E (1986)","DOI":"10.1016\/0002-9149(86)90716-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"H Scheinin, R Aantaa, M Anttila, et al.  \"Anesthesiology.\"  89, \"Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific \u03b1-adrenoceptor antagonist atipamezole.\" 574 (1989)","DOI":"10.1097\/00000542-199809000-00005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Z Szabo, DJ Venter, EDC Luyt, et al.  \"Acta Vet Hung.\"  63, \"The use of thiafentanil oxalate and azaperone for reversible immobilization of African buffalo (Syncerus caffer) within a nature reserve.\" 11 (2015)","DOI":"10.1556\/avet.2015.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"LL Wolfe, WR Lance, MW Miller,  \"J Wildl Dis.\"  40, \"Immobilization of mule deer with thiafentanil (A-3080) or thiafentanil plus xylazine.\" 282 (2004)","DOI":"10.7589\/0090-3558-40.2.282"},{"key":"18","doi-asserted-by":"crossref","unstructured":"JR. Zuba  and M. Greenberg  \"Miller-Fowler's zoo and wild animal medicine, Volume 9, Current therapy.\"  \"Use of naltrexone and atipamezole in emergency response to human exposure to ultra-potent opioids and alpha-2 agonists in zoo and wildlife medicine.\" 164 (2019)","DOI":"10.1016\/B978-0-323-55228-8.00027-8"}],"container-title":["Journal of Zoo and Wildlife Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:48:07Z","timestamp":1704797287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-zoo-and-wildlife-medicine\/volume-54\/issue-4\/2022-0106\/PROTOCOL-FOR-HUMAN-EXPOSURE-TO-OPIOIDS-AND-CONCENTRATED-MEDETOMIDINE-USED\/10.1638\/2022-0106.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1638\/2022-0106","relation":{},"ISSN":["1042-7260"],"issn-type":[{"value":"1042-7260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}